Cargando…
Discovery of Pyridone-Substituted Triazolopyrimidine Dual A(2A)/A(1) AR Antagonists for the Treatment of Ischemic Stroke
[Image: see text] Ischemic stroke is a complex systemic disease characterized by high morbidity, disability, and mortality. The activation of the presynaptic adenosine A(2A) and A(1) receptors modifies a variety of brain insults from excitotoxicity to stroke. Therefore, the discovery of dual A(2A)/A...
Autores principales: | Tang, Mei-Lin, Wen, Zi-Hao, Wang, Jing-Huan, Wang, Mei-Ling, Zhang, Heyanhao, Liu, Xin-Hua, Jin, Lin, Chang, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Chemical Society
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8919384/ https://www.ncbi.nlm.nih.gov/pubmed/35295085 http://dx.doi.org/10.1021/acsmedchemlett.1c00599 |
Ejemplares similares
-
Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase 1 (HDAC1) Dual Inhibitors Derived from the Natural Product Saprorthoquinone
por: Lin, Yang, et al.
Publicado: (2020) -
New Trifluoromethyl Triazolopyrimidines as Anti-Plasmodiumfalciparum Agents
por: Boechat, Núbia, et al.
Publicado: (2012) -
The synthesis and evaluation of triazolopyrimidines as anti-tubercular agents
por: Zuniga, Edison S., et al.
Publicado: (2017) -
Triazolopyrimidines Target Aerobic Respiration in Mycobacterium tuberculosis
por: Shelton, Catherine, et al.
Publicado: (2022) -
Design, Synthesis, and Evaluation of Anticonvulsant Activities of New Triazolopyrimidine Derivatives
por: Song, Mingxia, et al.
Publicado: (2022)